حدد سهمًا أو عملة مشفرة في شريط البحث للحصول على ملخص
medmix AG
MEDXmedmix AG designs, produces, and sells high-precision devices and services for the healthcare, consumer, and industrial end markets worldwide. The company operates through Dental, Drug Delivery, Surgery, Industry, and Beauty segments. The company offers dental products, including mixing tips, dispensers, needles, accessories, and service solutions for various applications, such as prosthetics, adhesives, restoratives, prevention, esthetics and endodontics; drug delivery devices that are used to inject fertility drugs and growth hormones; and to treat niche diabetes indications, osteoporosis, and rare diseases; and mixing and delivery devices which are used to inject bone tissue, and to apply hemostatic sealants for internal and external wound treatment during surgical procedures. It also produces and markets dispensers, mixing tips, cartridges, and mixers for two-component adhesives and sealants for use in the construction, transportation, electronics assembly, infrastructure, and DIY industries; and micro-brushes used for the application of makeup treatments, such as lash & brow serum or spot correctors, as well as for the application of skincare treatments, such as anti-aging treatments. It offers its products under the Mixpac, Transcodent, Cox, MK, Medmix, Haselmeier, and Geka brands. The company was founded in 1922 and is based in Baar, Switzerland. Address: Neuhofstrasse 20, Baar, Switzerland, 6340
Analytics
سعر الهدف في وول ستريت
22.19 CHFنسبة السعر إلى الأرباح
–العائد الربحي
5.12 %السنة الحالية
العام الماضي
الربع الحالي
الربع الأخير
السنة الحالية
العام الماضي
الربع الحالي
الربع الأخير
الشخصيات الرئيسية MEDX
تحليلات الأرباح MEDX
نمو الأرباح على مدى 5 سنوات
–النمو المستمر
–معدل الدفع 5 سنوات في المتوسط
3398 %تاريخ الأرباح MEDX
تقييم الأسهم MEDX
المالية MEDX
نتائج | 2019 | ديناميات |